Malaria parasite clearance.
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Following anti-malarial drug treatment asexual malaria parasite killing and clearance appear to be first order processes. Damaged malaria parasites in circulating erythrocytes are removed from the circulation mainly by the spleen. Splenic clearance functions increase markedly in acute malaria. Either the entire infected erythrocytes are removed because of their reduced deformability or increased antibody binding or, for the artemisinins which act on young ring stage parasites, splenic pitting of drug-damaged parasites is an important mechanism of clearance. The once-infected erythrocytes returned to the circulation have shortened survival. This contributes to post-artesunate haemolysis that may follow recovery in non-immune hyperparasitaemic patients. As the parasites mature Plasmodium vivax-infected erythrocytes become more deformable, whereas Plasmodium falciparum-infected erythrocytes become less deformable, but they escape splenic filtration by sequestering in venules and capillaries. Sequestered parasites are killed in situ by anti-malarial drugs and then disintegrate to be cleared by phagocytic leukocytes. After treatment with artemisinin derivatives some asexual parasites become temporarily dormant within their infected erythrocytes, and these may regrow after anti-malarial drug concentrations decline. Artemisinin resistance in P. falciparum reflects reduced ring stage susceptibility and manifests as slow parasite clearance. This is best assessed from the slope of the log-linear phase of parasitaemia reduction and is commonly measured as a parasite clearance half-life. Pharmacokinetic-pharmacodynamic modelling of anti-malarial drug effects on parasite clearance has proved useful in predicting therapeutic responses and in dose-optimization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 A comparison of parasite dynamics in human malaria infections as illustrated by Fairley [5] following his classic studies of induced malaria in volunteers. The total numbers of parasites in the body of an adult are shown in the vertical axes, and time in days is shown in the horizontal axis](https://figures.cochat.ai/paper-figures/05ea9100be1b4a4b9193ee391f577212/malaria-parasite-clearance-figure-1.jpg)
![Fig. 2 Parasite clearance times in adult Thai patients with vivax malaria after different treatments [28–30]. Parasite counts were determined at ≤6 h intervals on thin films, and at ≤12 h intervals on thick films. The open circles are individual asexual parasite clearance times, the closed circles are corresponding gametocyte clearance times, and the red diamonds denote failure to respond and administration of rescue treatment](https://figures.cochat.ai/paper-figures/59d4d276667945f3a88ec11bd7d502e2/malaria-parasite-clearance-figure-2.jpg)
![Fig. 3 Parasite clearance in acute falciparum malaria. Parasite counts were determined at ≤6 h intervals. These data are taken from studies in severe malaria for choroquine (in fully chloroquine sensitive malaria), quinine and artesunate, and in uncomplicated malaria for cipargamin [28, 33, 42, 56]](https://figures.cochat.ai/paper-figures/ea8c39105b6843d28af83d7aecd09643/malaria-parasite-clearance-figure-3.jpg)
![Fig. 4 Parasite clearance following the start of anti-malarial drug treatment with an ACT in falciparum malaria. After an initial and variable lag phase, which depends on the stage of parasite development, the decline in parasitaemia is generally log linear [23, 31, 32, 37, 38, 40, 42, 56, 97, 100, 122]. The rate constant of this decline, or its derivative half-life, is the best metric for the assessment of resistance to drugs acting on ring stage parasites-notably artemisinin derivatives [31, 37, 38, 40]. The simpler measure- the proportion of patients who have microscopy detectable parasitaemia on day 3 [100, 101] whilst useful for screening, is heavily dependent on starting parasite density; two infections with the same clearance half-lives (3 h) typically associated with full susceptibility to artemisinin derivative are compared with a 50-fold difference in admission parasitaemia which results in an 18-h difference in parasite clearance time. An artemisinin resistant infection (parasite clearance half-life 6 h) is shown for comparison [38]](https://figures.cochat.ai/paper-figures/2f28aa8d1590493f80ebe7bab97f2c0e/malaria-parasite-clearance-figure-4.jpg)
![Fig. 5 A thin immunofluorescence blood smear showing three red blood cells which stain positive for the P. falciparum ring erythrocyte stage antigen. The two lower cells also contain ring stage parasites which stain with acridine orange, the upper cell has no intraerythrocytic parasite indicating that it has already been removed by “pitting”. This is the main mechanism of ring stage parasite clearance in non-immune patients following treatment with artemisinin derivatives [34, 82, 83]](https://figures.cochat.ai/paper-figures/83b0a97759934c258187b8615de01143/malaria-parasite-clearance-figure-5.jpg)
![Fig. 6 Individual parasite clearance half-lives in relation to presenting parasite density (shown on a log scale per µL) in 6975 patients with acute uncomplicated falciparum malaria treated with an artemisinin derivative (from reference [32]). The upper panel shows data from areas unaffected by artemisinin resistance, the lower panel shows data from areas where artemisinin resistance is prevalent. There is no evidence for density dependence in parasite clearance rates](https://figures.cochat.ai/paper-figures/7b084f1de3ae4676b340f6ad1e5b5b35/malaria-parasite-clearance-figure-6.jpg)
![Fig. 7 Recrudescent falciparum malaria following administration of a slowly eliminated drug such as mefloquine, showing an example of the changes in total parasite numbers (blue) in the body as anti-malarial drug levels (red) first rise then fall. As drug levels fall below the minimum parasiticidal concentration (MPC) the rate of parasitaemia declines until it reaches reaching a temporary plateau, at which time the corresponding drug level is a minimum inhibitory concentration (MIC) [23, 117, 124]. Meanwhile levels of any dormant forms remain unchanged, while gametocyte densities rise as stage 5 gametocytes enter the circulation from sequestered sites. All contribute to qPCR parasite DNA measurements. Dormant forms are either cleared or “awaken” to form either asexual or sexual stages. The top right inset shows an individual patient example with female gametocyte specific Pfs 25 mRNA transcript densities shown in green and Pf18s DNA shown in blue (data from reference [124]). There are multiple mRNA transcripts per cell, but the rising DNA densities at the time of falling transcript numbers clearly indicates recrudescence](https://figures.cochat.ai/paper-figures/d2e97116d2084f14bb9328722a624731/malaria-parasite-clearance-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 2×
“For drugs which act on ring stage parasites the parasite clearance rate (or derived half-life) is currently the best in vivo measure of drug effect [31, 32, 37, 38, 40, 108, 122].”
BackgroundSelf-citationSpread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationA molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090 · cited 1×
“Artemisinin resistance is associated with mutations in the propeller region of the kelch protein [41].”
BackgroundWhite, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., & Dondorp, A. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60024-0 · Cited by 1,123
Self-citationDondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Self-citationMacPherson, G. G., Warrell, M. J., White, N. J., Looareesuwan, S., & Warrell, D. A. (1985) · PubMed Central · Cited by 825
Self-citationBousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746 · cited 1×
“falciparum malaria are relatively insensitive to most anti-malarial drugs (with the notable exception of the 8-aminoquinolines) whereas the gametocytes of the other human malaria parasites are considered as drug sensitive as their asexual counterparts [14, 16].”
BackgroundAssessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575 · cited 10×
“As drug levels fall below the minimum parasiticidal concentration (MPC) the rate of parasitaemia declines until it reaches reaching a temporary plateau, at which time the corresponding drug level is a minimum inhibitory concentration (MIC) [23, 117, 124].”
BackgroundInfluentialSelf-citationParasitologic and Clinical Human Response to Immunoglobulin Administration in Falciparum Malaria
Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun-Tayoun, H., Chantavanich, P., Foucault, C., Chongsuphajaisiddhi, T., & Druilhe, P. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.297 · Cited by 499 · cited 1×
“One Thai patient who received 200 mg/kg over 4 h reduced parasitaemia 160-fold within 2 h associated with rapid splenic enlargement [94].”
BackgroundWorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
Research works printed but not linked: 5
- World Health Organization. Severe malaria. Trop Med Int Health. 2014;19(Supplement 1):1–131.
- Marchiafava E, Bignami A. On summer-autumnal fever. London: New Sydenham Society; 1894.
- WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.
- Kitchen SF. Symptomatology: general considerations and falciparum malaria. In: Boyd MF, editor. Malariology, vol. 2. Philadelphia: WB Saunders; 1949. p. 996–1017.
- Kitchen SF. Vivax malaria. In: Boyd MF, editor. Malariology, vol. 2. Philadephia: WB Saunders; 1949. p. 1027–45.
Cited by
Evidence of Artemisinin-Resistant Malaria in Africa
Balikagala, B., Fukuda, N., Ikeda, M., Katuro, O. T., Tachibana, S.-I., Yamauchi, M., Opio, W., Emoto, S., Anywar, D. A., Kimura, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101746 · Cited by 866
Ashley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
Tissue-specific immunopathology during malaria infection
Coban, C., Lee, M. S. J., & Ishii, K. J. (2018) · Nature reviews. Immunology · doi:10.1038/nri.2017.138 · Cited by 113
Kho, S., Qotrunnada, L., Leonardo, L., Andries, B., Wardani, P. A. I., Fricot, A., Henry, B., Hardy, D., Margyaningsih, N. I., Apriyanti, D., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003632 · Cited by 121
“Even assuming a multiplication rate of 10 in peripheral blood (which is >50% efficiency for Pv in 1 cycle) [66], 99% splenic retention of IEs, and zero destruction by splenic macrophages or other intrasplenic processes, the resulting intrasplenic Pv parasitaemia of 0.”
BackgroundTissue tropism in parasitic diseases
Silva Pereira, S., Trindade, S., De Niz, M., & Figueiredo, L. M. (2019) · Open Biology · doi:10.1098/rsob.190036 · Cited by 85
Metadata
- Authors
- White, N. J.
- Affiliations
- Mahidol University (TH)
- Corresponding author
- White, Nicholas J.
- ORCID
- White, Nicholas J.
- Venue
- Malaria Journal
- Published
- 2017-02-23
- Volume
- 16
- Issue
- 1
- Pages
- 88-88
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC5324257
- OpenAlex
- W2589856587
- Cited by
- 230
- References
- 120
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 27 · 2023: 26 · 2022: 26 · 2021: 21 · 2020: 39 · 2019: 22 · 2018: 20 · 2017: 6
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-05-10)
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Physiology (medical) › Erythrocyte Function and Pathophysiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- splenic clearance, erythrocyte deformability, artemisinin resistance, Plasmodium falciparum, Plasmodium vivax, sequestration, ring-stage parasites, parasite dormancy, parasite clearance half-life, pharmacokinetic-pharmacodynamic modeling, hyperparasitemia, spleen
- MeSH terms
- Antimalarials, Erythrocytes, Half-Life, Humans, Malaria, Plasmodium, Parasitemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malaria parasite clearance. https://app.cochat.ai/papers/10.1186/s12936-017-1731-1
- The paper
- White, N. J. (2017). Malaria parasite clearance. Malaria Journal. https://doi.org/10.1186/s12936-017-1731-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.